TNF-alpha acts to prevent occurrence of malformed fetuses in diabetic mice

A Torchinsky1, M Gongadze, H Orenstein

  • 1Department of Embryology and Teratology, Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Tel Aviv 69978, Israel. arkadyt@post.tau.ac.il

Diabetologia
|December 3, 2003
PubMed
Abstract

Insights

Tumor necrosis factor-alpha (TNF-alpha) contributes to early embryo death in diabetic mice but protects later embryos from malformations by activating anti-apoptotic pathways. TNF-alpha appears to prevent malformed offspring in severely diabetic conditions.

Area of Science:

  • Reproductive biology
  • Developmental toxicology
  • Immunology

Background:

  • Diabetes-induced embryopathies, including early embryonic death and structural anomalies, are linked to apoptosis.
  • Tumor necrosis factor-alpha (TNF-alpha) has dual roles in apoptosis, potentially causing or preventing maldevelopment.

Purpose of the Study:

  • To investigate the role of TNF-alpha in regulating embryonic response to diabetes-induced stress.
  • To examine how TNF-alpha influences early embryonic death and malformations in diabetic conditions.

Main Methods:

  • Used streptozotocin-induced diabetic TNF-alpha knockout mice.
  • Assessed reproductive performance and fetal teratogenic effects.
  • Localized apoptotic nuclei using TUNEL assay and evaluated NF-kappaB activity via electrophoretic mobility shift assay.

Main Results:

  • Diabetic wild-type (TNF-alpha+/+) mice showed lower pregnancy rates but fewer malformed fetuses than diabetic TNF-alpha knockout (TNF-alpha-/-) mice.
  • Malformed TNF-alpha-/- embryos exhibited higher apoptosis intensity and lower active NF-kappaB levels compared to TNF-alpha(+/+) embryos.

Conclusions:

  • TNF-alpha promotes peri-implantation embryo death but protects post-implantation embryos from diabetes-induced teratogenic stimuli.
  • Activation of NF-kappaB-mediated anti-apoptotic signaling by TNF-alpha appears crucial for preventing malformed offspring in diabetic mice.